59 systems-science-"https:" "https:" "https:" Postdoctoral positions at University College Cork in Ireland
Sort by
Refine Your Search
-
Economy strand of the NorseMap Project based in the School of English and Digital Humanities at UCC. NorseMap is a 5-year project funded by the European Research Council, using citizen science methodologies
-
13 Mar 2026 Job Information Organisation/Company University College Cork Department HR Research Research Field Environmental science » Other Researcher Profile Established Researcher (R3) Positions
-
and Technology - MARQUIS Post Duration: 16 Months, Whole-Time Salary: €54,307 - €59,064 p.a. (IUA PD2 Scale) For an information package including further details of the post see https://ore.ucc.ie
-
and intelligent systems for industrial applications. Based within the School of Engineering and Architecture, IERG develops and applies cutting-edge analytics, modelling, and decision-support
-
-tailed eagles since their reintroduction to Ireland’. A total of 245 white-tailed eagle chicks have been reintroduced to Ireland since 2007 and there is now an established breeding population of about 15
-
– MARQUIS Post Duration: 12 Months, Full-Time Post Salary: €46,805 - €53,391 p.a. (IUA PD1 Salary Scale) For an information package including further details of the post see https://ore.ucc.ie/ Informal
-
19 Months, Fixed Term, whole-time Post A Post-Doctoral Researcher position is available at Cork University Business School (CUBS) to join a COALESCE project focused on global AI governance, trust
-
transition. We are seeking an enthusiastic, creative and self-motivated individual to contribute to the CLIMATUDE project funded by the Environmental Protection Agency. The project is working to develop an in
-
researching improvements in service delivery and professional practice. Achievement of the expected progression within Post Doc and Senior Post Doc is transferable between the Irish HEI’s. This can be
-
-income populations in developing countries, access to life-saving medicines is often fraught with obstacles. These include a lack of financial incentive for major pharmaceutical companies to develop